Establishment of a visualized mouse orthotopic xenograft model of nasopharyngeal carcinoma

Wei Chen1,2, Wei-Min Chen1, Si-Xia Chen1

  • 1Department of Radiation Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.

Cancer Biology & Therapy
|August 29, 2024
PubMed

Insights

Researchers developed a reproducible, visualized orthotopic xenograft model for nasopharyngeal carcinoma (NPC) in mice. This model aids in studying NPC progression and evaluating preclinical treatments, overcoming limitations of previous methods.

Area of Science:

  • Oncology
  • Preclinical Cancer Models
  • Translational Research

Background:

  • Orthotopic xenograft tumor models are crucial for studying cancer mechanisms and preclinical treatment efficacy.
  • The lack of mature, visualized orthotopic xenograft models for nasopharyngeal carcinoma (NPC) hinders treatment strategy development.
  • A reliable method for creating such models is needed to advance NPC research.

Purpose of the Study:

  • To establish a simple, reliable, and visualized orthotopic xenograft model for nasopharyngeal carcinoma (NPC).
  • To provide a platform for investigating NPC development, progression, and preclinical treatment strategies.

Main Methods:

  • Human NPC cells (C666-1-luc) expressing luciferase were injected subcutaneously into nude mice.
  • Subcutaneous tumors were harvested and grafted into the nasopharynx of immunodeficient mice.
  • Tumor growth was monitored using bioluminescence imaging and small animal MRI; histological and immunological antigen expression was analyzed via IHC.

Main Results:

  • A visualized orthotopic xenograft NPC model was successfully established in nude mice.
  • Tumor growth in the nasopharynx was confirmed by luminescence, micro-MRI, and H&E staining.
  • Immunohistochemistry confirmed the expression of key antigens (CK, CK5/6, P40, P63) consistent with human NPC.

Conclusions:

  • This study presents a reproducible, visual, and less lethal orthotopic xenograft model for nasopharyngeal carcinoma.
  • The developed model serves as a valuable platform for preclinical research and the advancement of NPC treatment strategies.